Education
About Us
Working with TipRanks
Follow Us
ClouDr Group Limited (HK:9955)
:9955
9955 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$1.05 - HK$5.03
Previous CloseN/A
Volume146.50K
Average Volume (3M)6.44M
Market Cap
HK$820.62M
Enterprise ValueHK$869.32M
Total Cash (Recent Filing)¥224.18M
Total Debt (Recent Filing)¥574.09M
Price to Earnings (P/E)―
Beta1.96
Next Earnings
Mar 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.55
Shares Outstanding645,718,800
10 Day Avg. Volume5,414,595
30 Day Avg. Volume6,439,550
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.98
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
ClouDr Group Limited News
PremiumCompany Announcements
ClouDr Group Enhances AI Capabilities with DeepSeek-R1 Integration
PremiumCompany Announcements
ClouDr Group Limited Revamps Equity Incentive Scheme with New Share Awards
PremiumCompany Announcements
ClouDr Group Limited Announces Change of Business Address in Hong Kong
PremiumCompany Announcements
ClouDr Group Approves New Share Scheme and Limits
PremiumCompany Announcements
ClouDr Group Limited to Discuss New Share Scheme
PremiumCompany Announcements
ClouDr Group Limited Names New Executive Director
PremiumCompany Announcements
ClouDr Group Launches AI-Driven Diabetes Drug
PremiumCompany Announcements
ClouDr Group Secures Strategic Alliance with Medice---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
― Other Institutional Investors
99.98% Public Companies and
Individual Investors
9955 FAQ
What was ClouDr Group Limited’s price range in the past 12 months?
ClouDr Group Limited lowest stock price was HK$1.05 and its highest was HK$5.03 in the past 12 months.
What is ClouDr Group Limited’s market cap?
ClouDr Group Limited’s market cap is HK$820.62M.
When is ClouDr Group Limited’s upcoming earnings report date?
ClouDr Group Limited’s upcoming earnings report date is Mar 20, 2025 which is in 11 days.
How were ClouDr Group Limited’s earnings last quarter?
ClouDr Group Limited released its earnings results on Aug 21, 2024. The company reported -HK$0.214 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.214.
Is ClouDr Group Limited overvalued?
According to Wall Street analysts ClouDr Group Limited’s price is currently Overvalued.
Does ClouDr Group Limited pay dividends?
ClouDr Group Limited does not currently pay dividends.
What is ClouDr Group Limited’s EPS estimate?
ClouDr Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ClouDr Group Limited have?
ClouDr Group Limited has 645,718,800 shares outstanding.
What happened to ClouDr Group Limited’s price movement after its last earnings report?
ClouDr Group Limited reported an EPS of -HK$0.214 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.896%.
Which hedge fund is a major shareholder of ClouDr Group Limited?
Currently, no hedge funds are holding shares in HK:9955
---
ClouDr Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-70.94%
12-Months-Change
Fundamentals
Return on Equity
-15.96%
Trailing 12-Months
Asset Growth
8.62%
Trailing 12-Months
Company Description
ClouDr Group Limited
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solution, pharmacy solution, and individual chronic condition management solution. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.
---
9955 Stock 12 Month Forecast
Average Price Target
―Technical Analysis
China Modern Dairy Holdings Ltd.
―
Hospital Corporation of China Ltd
―
CanSino Biologics, Inc. Class H
―
Shanghai Haohai Biological Technology Co., Ltd. Class H
―
---